Overview

Adjuvant Treatment for Incomplete Resection Thymoma or Thymic Carcinoma

Status:
Recruiting

Trial end date:
2026-12-01

Target enrollment:
0

Participant gender:
All

Summary

This study is designed to investigate whether adjuvant radiochemotherapy after incomplete resection has a better survival than adjuvant radiotherapy for thymoma or thymic carcinoma.

Phase:

Phase 3

Accepts Healthy Volunteers?

Details

Lead Sponsor:

Fudan University

Treatments:

Etoposide

Criteria

Inclusion Criteria:

18~75 years old; Eastern Cooperative Oncology Group performance status of 0 to 2;
Pathologically confirmed ; incomplete resection (R1 or R2);have adequate bone marrow,
hepatic, and renal function;Patients receive incomplete resection within 3 months; Written
informed consent.

Exclusion Criteria:

Patients with distant metastases; Patients underwent radiotherapy or chemotherapy; Patients
who have malignancy history excluding carcinoma in situ of cervix in the previous five
years; Active clinical pulmonary infection; Pregnant or nursing.